Cart
sales@molnova.com
Anemarrhenasaponin Ia
CAS No. 221317-02-8
Anemarrhenasaponin Ia( —— )
Catalog No. M29402 CAS No. 221317-02-8
Anemarrhenasaponin Ia, an useful anti-inflammation reagent, is isolated from Anemarrhenae rhizome. Anemarrhenasaponin Ia inhibits the generation of N-formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 135 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAnemarrhenasaponin Ia
-
NoteResearch use only, not for human use.
-
Brief DescriptionAnemarrhenasaponin Ia, an useful anti-inflammation reagent, is isolated from Anemarrhenae rhizome. Anemarrhenasaponin Ia inhibits the generation of N-formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide.
-
DescriptionAnemarrhenasaponin Ia, an useful anti-inflammation reagent, is isolated from Anemarrhenae rhizome. Anemarrhenasaponin Ia inhibits the generation of N-formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number221317-02-8
-
Formula Weight772.97
-
Molecular FormulaC40H68O14
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOC1(CCC(C)C)O[C@H]2[C@H](O)C3[C@@H]4CC[C@@H]5C[C@H](CC[C@]5(C)[C@H]4CC[C@]3(C)C2[C@@H]1C)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
K-G-D-S
KGDS is synthetic peptides, targeting integrin GPIIb-IIIa located on the membrane of human activated platelets. Amino acid sequence: Lys-Gly-Asp-Ser.
-
Dasatinib N-oxide
Dasatinib N-oxide is a major metabolite of the Abl and Src kinase inhibitor dasatinib.It is also a potential impurity in commercial preparations of dasatinib.
-
Ebopiprant
Ebopiprant (OBE022) is an orally available, selective and potent prostaglandin F2α (PGF2α) receptor antagonist that interferes with the binding of PGF0126α to the FPR and can be used in the study of obesity.
